210 related articles for article (PubMed ID: 30423338)
41. A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation.
Thiel C; Schneckener S; Krauss M; Ghallab A; Hofmann U; Kanacher T; Zellmer S; Gebhardt R; Hengstler JG; Kuepfer L
J Pharm Sci; 2015 Jan; 104(1):191-206. PubMed ID: 25393841
[TBL] [Abstract][Full Text] [Related]
42. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
Poulin P; Burczynski FJ; Haddad S
J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
[TBL] [Abstract][Full Text] [Related]
43. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
Tsaioun K; Blaauboer BJ; Hartung T
ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179
[TBL] [Abstract][Full Text] [Related]
44. An update on computational oral absorption simulation.
Dressman JB; Thelen K; Willmann S
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1345-64. PubMed ID: 21939427
[TBL] [Abstract][Full Text] [Related]
45. Our "Collegium Antropologicum" officially the most improved social science journal in the world for mid-2002.
Rudan P; Skarić-Jurić T; Rudan I
Coll Antropol; 2003 Jun; 27(1):S1-4. PubMed ID: 12974128
[TBL] [Abstract][Full Text] [Related]
46. Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper.
Ball K; Bruin G; Escandón E; Funk C; Pereira JNS; Yang TY; Yu H
Drug Metab Dispos; 2022 Jun; 50(6):858-866. PubMed ID: 35149542
[TBL] [Abstract][Full Text] [Related]
47. Pharmaceutical technology, biopharmaceutics and drug delivery.
Youn YS; Lee BJ
Ther Deliv; 2011 Mar; 2(3):297-9. PubMed ID: 22833999
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the whole body physiologically based pharmacokinetic (WB-PBPK) modeling of drugs.
Munir A; Azam S; Fazal S; Bhatti AI
J Theor Biol; 2018 Aug; 451():1-9. PubMed ID: 29704489
[TBL] [Abstract][Full Text] [Related]
49. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
Liyanage SS; Raina Macintyre C
Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128
[TBL] [Abstract][Full Text] [Related]
50. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
Johnson TN; Rostami-Hodjegan A
Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
[TBL] [Abstract][Full Text] [Related]
51. Drug company links test journal's policy.
Wadman M
Nature; 1996 Sep; 383(6595):6. PubMed ID: 8779701
[No Abstract] [Full Text] [Related]
52. Manufacturing of biopharmaceuticals and implications for biosimilars.
Wurm FM
Kidney Blood Press Res; 2007; 30 Suppl 1():6-8. PubMed ID: 17726336
[No Abstract] [Full Text] [Related]
53. The role of international journals in legal/forensic medicine.
Saukko P
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S9-12. PubMed ID: 19269225
[TBL] [Abstract][Full Text] [Related]
54. Computational science in drug metabolism and toxicology.
Valerio LG
Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):781-4. PubMed ID: 20465524
[TBL] [Abstract][Full Text] [Related]
55. Archives of Drug Information-A New Approach to Publishing the Results of Drug Studies.
Stein CM
Arch Drug Inf; 2008 Jul; 1(1):1-3. PubMed ID: 20157348
[TBL] [Abstract][Full Text] [Related]
56. A review of contributions to disasters: 1977-1996.
Kelly C
Disasters; 1998 Jun; 22(2):144-56. PubMed ID: 9654813
[TBL] [Abstract][Full Text] [Related]
57. Computational toxicology: application in environmental chemicals.
Tan YM; Conolly R; Chang DT; Tornero-Velez R; Goldsmith MR; Peterson SD; Dary CC
Methods Mol Biol; 2012; 929():9-19. PubMed ID: 23007424
[TBL] [Abstract][Full Text] [Related]
58. Modeling & Informatics at Vertex Pharmaceuticals Incorporated: our philosophy for sustained impact.
McGaughey G; Patrick Walters W
J Comput Aided Mol Des; 2017 Mar; 31(3):293-300. PubMed ID: 27900588
[TBL] [Abstract][Full Text] [Related]
59. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
Hafner J
J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
[TBL] [Abstract][Full Text] [Related]
60. Have physiologically-based pharmacokinetic models delivered?
Edginton AN; Joshi G
Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):929-34. PubMed ID: 21762039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
